Biogen Inc. - Net Worth and Insider Trading
Biogen Inc. Net Worth
The estimated net worth of Biogen Inc. is at least $34 Million dollars as of 2024-11-05. Biogen Inc. is the 10% Owner of Sangamo Therapeutics Inc and owns about 17,652,466 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $33 Million. Biogen Inc. is also the 10% Owner of Tecogen Inc and owns about 508,673 shares of Tecogen Inc (TGEN) stock worth over $432,372. Details can be seen in Biogen Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Biogen Inc. has not made any transactions after 2023-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Biogen Inc.
Biogen Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biogen Inc. owns 8 companies in total, including Denali Therapeutics Inc (DNLI) , Sangamo Therapeutics Inc (SGMO) , and Bioverativ Inc (BIVV) among others .
Click here to see the complete history of Biogen Inc.’s form 4 insider trades.
Insider Ownership Summary of Biogen Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DNLI | Denali Therapeutics Inc | 2020-09-22 | 10 percent owner |
| SGMO | Sangamo Therapeutics Inc | 2023-09-26 | 10 percent owner |
| BIVV | Bioverativ Inc | 2017-02-01 | 10 percent owner |
 | | 2002-09-25 | 10 percent owner |
| | 2005-09-27 | 10 percent owner |
| | 2005-09-27 | 10 percent owner |
| | 2020-12-31 | 10 percent owner |
| | 2023-07-28 | other: See footnotes |
Biogen Inc. Latest Holdings Summary
Biogen Inc. currently owns a total of 2 stocks. Among these stocks, Biogen Inc. owns 17,652,466 shares of Sangamo Therapeutics Inc (SGMO) as of September 26, 2023, with a value of $33 Million and a weighting of 98.72%. Biogen Inc. also owns 508,673 shares of Tecogen Inc (TGEN) as of September 25, 2002, with a value of $432,372 and a weighting of 1.28%.
Latest Holdings of Biogen Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2023-09-26 | 17,652,466 | 1.88 | 33,266,072 |
| TGEN | Tecogen Inc | 2002-09-25 | 508,673 | 0.85 | 432,372 |
Holding Weightings of Biogen Inc.
Biogen Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Biogen Inc. has made a total of 8 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Sangamo Therapeutics Inc is the sale of 6,000,000 shares on September 26, 2023, which brought Biogen Inc. around $3 Million.
According to the SEC Form 4 filings, Biogen Inc. has made a total of 0 transactions in Tecogen Inc (TGEN) over the past 5 years. The most-recent trade in Tecogen Inc is the sale of 0 shares on September 25, 2002, which brought Biogen Inc. around $0.
Insider Trading History of Biogen Inc.
- 1
Biogen Inc. Trading Performance
Biogen Inc. Ownership Network
Ownership Network List of Biogen Inc.
Ownership Network Relation of Biogen Inc.
Biogen Inc. Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Biogen Inc. is the 10 percent owner of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include director & President and CEO Ryan J. Watts , CFO and Treasurer Steve E. Krognes , and COO and Secretary Alexander O. Schuth .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Biogen Inc. made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 25,506 shares made by Vicki L Sato , a net sale of 83,768 shares made by Alexander O. Schuth , and a net sale of 54,249 shares made by Carole Ho .
In summary, during the past 3 months, insiders sold 113,507 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 113,507 shares. During the past 18 months, 459,258 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 459,258 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Biogen Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Biogen Inc.. You might contact Biogen Inc. via mailing address: 225 Binney Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
